LeMaitre Vascular, Inc. (LMAT), a medical device company, said on Monday that it intends to offer $150 million of convertible senior notes due 2030 in a private offering.
The company plans to use the net proceeds from this offering for working capital and other general purposes.
LeMaitre Vascular also expects to grant the initial purchasers of the notes an option to purchase up to an additional $22.500 million of notes.
LMAT was down by 4.16 percent at $96.50 in the pre-market trade on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.